The potential risk of tumor progression after use of dehydrated human amnion/chorion membrane allograft in a positive margin resection model.

The use of dHACM after partial tumor resection is related to faster tumor relapse and growth in prostate and urothelial cancer in vivo models, showing a potential risk of rapid local recurrence in patients at high risk of positive margins.